KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) EBIT (2016 - 2026)

Medtronic's EBIT history spans 13 years, with the latest figure at $1.5 billion for Q1 2026.

  • On a quarterly basis, EBIT fell 11.06% to $1.5 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $6.0 billion, a 8.24% increase, with the full-year FY2025 number at $6.0 billion, up 15.77% from a year prior.
  • EBIT hit $1.5 billion in Q1 2026 for Medtronic, down from $1.7 billion in the prior quarter.
  • Over the last five years, EBIT for MDT hit a ceiling of $1.7 billion in Q4 2025 and a floor of $1.1 billion in Q2 2024.
  • Historically, EBIT has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2025.
  • Biggest five-year swings in EBIT: plummeted 32.72% in 2024 and later skyrocketed 36.37% in 2025.
  • Tracing MDT's EBIT over 5 years: stood at $1.4 billion in 2022, then decreased by 4.56% to $1.3 billion in 2023, then grew by 19.03% to $1.6 billion in 2024, then increased by 5.71% to $1.7 billion in 2025, then decreased by 13.17% to $1.5 billion in 2026.
  • Business Quant data shows EBIT for MDT at $1.5 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.4 billion in Q3 2025.